Skip to main content
SpringerLink
Log in
Book cover

Glaucoma pp 137–155Cite as

Future of IOP-Lowering Medication for Glaucoma Therapy

  • Chapter

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alonso MJ, Sanchez A (2003) The potential of chitosan in ocular drug delivery. J Pharm Pharmacol 55:1451–1463

    Article  PubMed  CAS  Google Scholar 

  2. Bahler CK, Hann CR, Fautsch MP, et al (2004) Pharmacologic disruption of Schlemm’s canal cells and outflow facility in anterior segments of human eyes. Invest Ophthalmol Vis Sci 45:2246–2254

    Article  PubMed  Google Scholar 

  3. Bies C, Lehr C-M, Woodley JF (2004) Lectin-mediated drug targeting: history annd applications. Adv Drug Deliv Rev 56:425–435

    Article  PubMed  CAS  Google Scholar 

  4. Chen Z, Gu Q, Kaufman PL, et al (1998) Histochemical mapping of NADPH-diaphorase in monkey and human eyes. Curr Eye Res 17:370–379

    PubMed  CAS  Google Scholar 

  5. Chien FY, Wang RF, Mittag TW, et al (2003) Effect of WIN 55212-2, a cannabinoid receptor agonist, on aqueous humor dynamics in monkeys. Arch Ophthalmol 121:87–90

    PubMed  CAS  Google Scholar 

  6. Civan MM (2004) Potential role of purine in cross-talk linking inflow and outflow. Invest Ophthalmol Vis Sci 45(Suppl):Abs no. 4616

    Google Scholar 

  7. Daines BS, Kent AR, McAleer MS, et al (2003) Intraocular adenosine levels in normal annd ocular-hypertensive patients. J Ocul Pharmacol Ther 19:113–119

    Article  PubMed  CAS  Google Scholar 

  8. Filla MS, Liu X, Nguyen TD, et al (2002) In vitro localization of TIGR/MYOC in trabecular meshwork extracellular matrix and binding to fibronectin. Invest Ophthalmol Vis Sci 43:151–161

    PubMed  Google Scholar 

  9. Gabelt BT, Kaufman PL (2003) Aqueous humor hydrodynamics. In: Kaufman PL, Alm A (eds) Adler’s physiology of the eye; Clinical application. Mosby, St. Louis

    Google Scholar 

  10. Gabelt BT, Hu Y, Vittitow JL, et al (2006) Caldesmon transgene expression disrupts focal adhesion in HTM cells and increases outflow facility in organ-cultured human and monkey anterior segments. Exp Eye Res Polansky, Special Issue:IN PRESS

    Google Scholar 

  11. Gabelt BT, Kaufman PL (2005) Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res 24:612–637

    Article  PubMed  CAS  Google Scholar 

  12. Gonzalez JM, Peters DMP (2004) Heparin II (Hep II) binding domain of fibronectin disrupts cell-cell junctions in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 45(Suppl): Abs no. 4423

    Google Scholar 

  13. Gonzalez P, Caballero M, Liton PB, et al (2004) Expression analysis of the matrix GLA protein and VE-cadherin gene promoters in the outflow pathway. Invest Ophthalmol Vis Sci 45:1389–1395

    Article  PubMed  Google Scholar 

  14. Gulsen D, Chauhan A (2004) Ophthalmic drug delivery through contact lenses. Invest Ophthalmol Vis Sci 45:2342–2347

    Article  PubMed  Google Scholar 

  15. Helfman DM, Lemy ET, Berthier C, et al (1999) Caldesmon inhibits nonmuscle cell contractility and interferes with the formation of focal adhesions. Mol Biol Cell 10:3097–3112

    PubMed  CAS  Google Scholar 

  16. Hille K, Draeger J, Eggers T, et al (2001) Technical construction, calibration and results with a new intraocular pressure sensor with telemetric transmission. Klin Monat Augenheil 218:376–380

    Article  CAS  Google Scholar 

  17. Hornof M, Weyenberg W, Ludwig A, et al (2003) Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans. J Control Release 89:419–428

    Article  PubMed  CAS  Google Scholar 

  18. Inatani M, Tokushige H, Nemoto S, et al (2005) Intraocular pressure-lowering effects of topical administration of Y-39983, a novel selective rhoassociated protein kinase inhibitor. Invest Ophthalmol Vis Sci 46(Suppl): Abs no. 3787

    Google Scholar 

  19. Kaufman PL, Tian B, Gabelt BT, et al (2000) Out-flow enhancing drugs and gene therapy in glaucoma. In: Weinreb R, Krieglstein G, Kitazawa Y (eds) Glaucoma in the 21st century. Harcourt-Mosby, London

    Google Scholar 

  20. Kaur IP, Smitha R (2002) Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Devel Indust Pharm 28:353–369

    Article  CAS  Google Scholar 

  21. Kaur IP, Garg A, Singla AK, et al (2004) Vesicular systems in ocular drug delivery: an overview. Int J Pharmaceut 269:1–14

    Article  CAS  Google Scholar 

  22. Kee C, Sohn S, Hwang J-M (2001) Stromelysin gene transfer into cultured human trabecular cells and rat trabecular meshwork in vivo. Invest Ophthalmol Vis Sci 42:2856–2860

    PubMed  CAS  Google Scholar 

  23. Kharlamb AB, Krauss AH, Chen J, et al (2004) Prostanoid EP4 receptor stimulation produces profound ocular hypotension that involves pressure dependent outflow. Invest Ophthalmol Vis Sci 45(Suppl):Abs no. 1035

    Google Scholar 

  24. Kiland JA, Gabelt BT, Kaufman PL (2004) Studies on the mechanism of action of timolol and on the effects of suppression and redirection of aqueous flow on outflow facility. Exp Eye Res 78:639–651

    Article  PubMed  CAS  Google Scholar 

  25. Leonardi M, Leuenberger P, Bertrand D, et al (2004) First steps toward noninvasive intraocular pressure monitoring with a sensing contact lens. Invest Ophthalmol Vis Sci 45:3113–3117

    Article  PubMed  Google Scholar 

  26. Liu X, Wu Z, Sheibani N, et al (2003) Low dose latrunculin-A inhibits dexamethasone-induced changes in the actin cytoskeleton and alters extracellular matrix protein expression in cultured human trabecular meshwork cells. Exp Eye Res 77:181–188

    Article  PubMed  CAS  Google Scholar 

  27. Liu X, Hu Y, Filla MS, et al (2005) The effects of C3 transgene expression on actin and cellular adhesions in cultured human trabecular meshwork cells and on outflow facility in organ cultured monkey eyes. Mol Vis 11:1112–1121

    PubMed  Google Scholar 

  28. Lograno MD, Romano MR (2004) Cannabinoid agonists induce contractile responses through Gi/o-dependent activation of phospholipase C in the bovine ciliary muscle. Eur J Pharmacol 494:55–62

    Article  PubMed  CAS  Google Scholar 

  29. Lütjen-Drecoll E (2000) Conventional and uveoscleral routes. In: Weinreb RN, Kitazawa Y, Krieglstein GK (eds) Glaucoma in the 21st century. Harcourt Health Communications, London

    Google Scholar 

  30. Lütjen-Drecoll E (1998) Functional morphology of the trabecular meshwork in primate eyes. Prog Retinal Eye Res 18:91–119

    Article  Google Scholar 

  31. May JC, McLaughlin MA, Sharif NA, et al (2003) Evaluation of the ocular hypotensive response of serotonin 5-HT1A and 5-HT-2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys. J Pharmacol Exp Ther 306:301–309

    Article  PubMed  CAS  Google Scholar 

  32. Nilsson S, Nieves AL, Guerra T, et al (2004) Effect of EP2-agonists on the outflow of aqueous humor in the cynomolgus monkey. Invest Ophthalmol Vis Sci 45(Suppl):Abs no. 4663

    Google Scholar 

  33. Gabelt BT, Okka M, Dean RT, et al (2005) Aqueous humor dynamics in monkeys after topical RDOI. Invest Ophthalmol Vis Sci 46:4691–4694

    Article  PubMed  Google Scholar 

  34. Okka M, Tian B, Kaufman PL (2004) Effect of low-dose latrunculin B on anterior segment physiologic features in the monkey eye. Arch Ophthalmol 122:1482–1488

    Article  PubMed  CAS  Google Scholar 

  35. Polska E, Ehrlich P, Luksch A, et al (2003) Effects of adenosine on intraocular pressure, optic nerve head blood flow, and choroidal blood flow in healthy humans. Invest Ophthalmol Vis Sci 44:3110–3114

    Article  PubMed  Google Scholar 

  36. Porcella A, Chiara M, Gessa GL, et al (2001) The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies. Eur J Neurosci 13:409–412

    Article  PubMed  CAS  Google Scholar 

  37. Potter DE, Russell KRM, Manhiani M (2004) Bremazocine increases C-type natriuretic peptide levels in aqueous humor and enhances outflow facility. J Pharmacol Exp Ther 309:548–553

    Article  PubMed  CAS  Google Scholar 

  38. Rao PV, Deng P, Maddala R, et al (2005) Expressions of dominant negative Rho-binding domaine of Rho-kinease in organ cultured human eye anterior segments increases aqueous humor outflow. Mol Vis 11:288–297

    PubMed  CAS  Google Scholar 

  39. Rauz S, Cheung CMG, Wood PJ, et al (2003) Inhibition of 11b-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension. Q J Med 96:481–490

    CAS  Google Scholar 

  40. Richter M, Krauss AH-P, Woodward DF, et al (2003) Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide. Invest Ophthalmol Vis Sci 44:4419–4426

    Article  PubMed  Google Scholar 

  41. Rüdiger M (1998) Vinculin and a-catenin: shared and unique functions in adherens junctions. Bioessays 20:733–740

    Article  PubMed  Google Scholar 

  42. Sabanay I, Gabelt BT, Tian B, et al (2000) H-7 effects on structure and fluid conductance of monkey trabecular meshwork. Arch Ophthalmol 118:955–962

    PubMed  CAS  Google Scholar 

  43. Sanka RK, Epstein DL, Rao PV (2005) Actin depolymerizing agents induce activation of MMP-2 in trabecular meshwork cells. Invest Ophthalmol Vis Sci 46(ARVO Suppl):Abs no. 1352

    Google Scholar 

  44. Shahidullah M, Yap M, To CH (2005) Cyclic GMP, sodium nitroprusside and sodium azide reduce aqueous humor formation in the arterially perfused pig eye. Br J Pharmacol 145:84–92

    Article  PubMed  CAS  Google Scholar 

  45. Song Y, Wang Y, Thakur R, et al (2004) Mucosal drug delivery: membranes, methodologies, and applications. Crit Rev Therap Drug Carrier Syst 21:195–256

    Article  CAS  Google Scholar 

  46. Takagi Y, Nakajima T, Shimazaki A, et al (2004) Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Exp Eye Res 78:767–776

    Article  PubMed  CAS  Google Scholar 

  47. Tian B, Kaufman PL (2004) Effects of the Rho kinase inhibitor Y-27632 and the phosphatase inhibitor calyculin A on outflow facility in monkeys. Exp Eye Res 80:215–225

    Article  Google Scholar 

  48. Tian B, Sabanay I, Gabelt BT, et al (2004) Latrunculin B effects on aqueous outflow and trabecular meshwork and corneal endothelium structure in the monkey eye. Invest Ophthalmol Vis Sci 45: Abs no. 2092

    Google Scholar 

  49. Wiederholt M, Helbig H, Korbmacher C (1991) Ion transport across the ciliary epithelium: lessons from cultured cells and proposed role of the carbonic anhydrase. In: Botrè F, Gross G (eds) Carbonic anhydrase. Verlag-Chemie, Cambridge

    Google Scholar 

  50. Zhao X, Pearson KE, Stephan DA, et al (2003) Effects of prostaglandin analogs on human ciliary muscle and trabecular meshwork cells. Invest Ophthalmol Vis Sci 44:1945–1952

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, University of Wisconsin, 600 Highland Avenue, Madison, WI, 53792-3284, USA

    Paul L. Kaufman MD, PhD (Professor and Chairman)

  2. Department of Ophthalmology and Visual Sciences, University of Wisconsin, 600 Highland Avenue, Madison, WI, 53792-3284, USA

    B’Ann True Gabelt (Associate Scientist)

Authors
  1. Paul L. Kaufman MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B’Ann True Gabelt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Ophthalmology, University of Wuerzburg, Josef-Schneider-Straße 11, 97080, Wuerzburg, Germany

    Franz Grehn MD (Professor and Chairman) (Professor and Chairman)

  2. Department of Ophthalmology, USCF, 10 Kirkham Street, Rm K301, San Francisco, CA, 94143, USA

    Robert Stamper MD (Director of Glaucoma Service) (Director of Glaucoma Service)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kaufman, P.L., Gabelt, B.T. (2006). Future of IOP-Lowering Medication for Glaucoma Therapy. In: Grehn, F., Stamper, R. (eds) Glaucoma. Essentials in Ophthalmology. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-34773-9_9

Download citation

  • DOI: https://doi.org/10.1007/3-540-34773-9_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-26220-6

  • Online ISBN: 978-3-540-34773-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation